Praeventix, Inc.
Biotechnology company · Exton, Pennsylvania, United States
Praeventix, Inc. is a biotechnology company headquartered in Exton, Pennsylvania, United States. Its earliest recorded incorporation is in 2022. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $8.1 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2026.
Praeventix at a glance
What does Praeventix do?
US government research funding
7 SBIR/STTR small-business research awards from US health agencies, $8.1 million in total (2017 to 2023). NIH funding came from the National Institute on Drug Abuse, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $3 million sold (2026).
Frequently asked questions about Praeventix
Where is Praeventix headquartered?
Praeventix, Inc. is headquartered in Exton, Pennsylvania, United States.
What does Praeventix do?
Praeventix, Inc. is a biotechnology company.
When was Praeventix founded?
The earliest incorporation on record for Praeventix, Inc. is in 2022, according to public company registers.
Similar companies
- Aceragen, Inc.Exton, Pennsylvania, United States
- Absorption Systems LLCExton, Pennsylvania, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences